Findings

What do systematic reviews say?

16 questions · 16 findings · 9 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 12.5%GRADE not reported 2 · 12.5%Very low 9 · 56.3%Low 3 · 18.8%Moderate 0 · 0%High 0 · 0%

SUPPORTIVE THERAPY vs cognitive behavioural therapy

Quality of life RSES · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 65 participants
Very low

SUPPORTIVE THERAPY vs FAMILY THERAPY

Quality of life ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SUPPORTIVE THERAPY vs ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT

Quality of life QLS · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Very low

SUPPORTIVE THERAPY vs PSYCHOEDUCATION

Quality of life QLS · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Very low

SUPPORTIVE THERAPY vs usual care

Quality of life WBS · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
Very low

Group B cognitive behavioural therapy: cognitive behavioural therapy + supportive therapy vs supportive therapy

Quality of Life Manchester Short Assessment (MANSA) · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 140 participants
Very low

Summary of findings table (subcomparison 1): chemotherapy or targeted therapy plus best supportive care (BSC) vs BSC

Quality of life · palliative participants with esophageal and GE‐junction carcinoma

1 finding from 1 review

Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer 2017 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1129 participants
Very low

Group C cognitive behavioural therapy: cognitive behavioural therapy + supportive intervention vs non‐directive reflective listening + supportive intervention

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Daily conventionally fractionated radiotherapy vs supportive care

Quality of life · high‐grade glioma

1 finding from 1 review

External beam radiation dose escalation for high grade glioma 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 81 participants
GRADE not reported

Biological therapy vs placebo, best supportive care (BSC) or no treatment

QoL · advanced gastric and oesophago‐gastric junction adenocarcinoma

1 finding from 1 review

Salvage systemic therapy for advanced gastric and oesophago‐gastric junction adenocarcinoma 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 283 participants
Low

Avatar Therapy vs supportive counselling (all short‐term)

Quality of Life Manchester Short Assessment (MANSA) · schizophrenia or related disorders

1 finding from 1 review

Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 120 participants
Low

Pexastimogene devacirepvec (Pexa‐Vec) plus best supportive care vs best supportive care

Health‐related quality of life · participants with advanced hepatocellular carcinoma

1 finding from 1 review

Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 129 participants
Very low

Group C cognitive behavioural therapy: cognitive behavioural therapy + placebo vs placebo or supportive treatment

Quality of life QLS · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Very low

Group C cognitive behavioural therapy: cognitive behavioural therapy + risperidone vs placebo or supportive treatment

Quality of life QLS · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

Intervention not reported

Quality of life · patients with extensive SCLC who relapsed or progressed after first‐line chemotherapy

The intervention may leads to higher quality of life (low certainty).

1 finding from 1 review

Chemotherapy versus best supportive care for extensive small cell lung cancer 2013 · Cochrane Headline outcomes only
RR 2.18 [0.05, 0.25]
1 study · 141 participants
Low

Gemcitabine plus oxaliplatin vs best supportive care

Health‐related quality of life · people with advanced biliary tract carcinomas

The review found no eligible studies for this question.

1 finding from 1 review

Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found